SCOPUS 정보 검색 플랫폼

Assay and Drug Development Technologies

Volumn 14, Issue 10, 2016, Pages 554-556

Revisiting Repurposing

(1) Sharlow, Elizabeth R a

a UNIVERSITY OF VIRGINIA (United States)

Author keywords

Drug library; Drug repurposing; Drug rescue

Indexed keywords

DRUG;

ARTICLE; DRUG DEVELOPMENT; DRUG EFFICACY; DRUG REPOSITIONING; DRUG SAFETY; FOOD AND DRUG ADMINISTRATION; HIGH THROUGHPUT SCREENING; HUMAN; ANIMAL; DRUG APPROVAL; PROCEDURES; TRENDS; UNITED STATES;

ANIMALS; DRUG APPROVAL; DRUG DISCOVERY; DRUG REPOSITIONING; HUMANS; UNITED STATES;

EID: 85006791106 PISSN: 1540658X EISSN: 15578127 Source Type: Journal
DOI: 10.1089/adt.2016.766 Document Type: Article

Times cited : (15)

References (8)

1
- 4344692338
- The American Diabetes Association, and the American Heart Association Collaborative Writing Committee: Preventing cancer, cardiovascular disease, and diabetes: A common agenda for the American Cancer Society, the American Diabetes Association, and the American Heart Association
- Eyre H, Kahn R, Robertson RM; American Cancer Society, the American Diabetes Association, and the American Heart Association Collaborative Writing Committee: Preventing cancer, cardiovascular disease, and diabetes: a common agenda for the American Cancer Society, the American Diabetes Association, and the American Heart Association. CA Cancer J Clin 2004;54:190-207.
- (2004) CA Cancer J Clin , vol.54 , pp. 190-207
- Eyre, H.¹ Kahn, R.² Robertson, R.M.³ Cancer Society, A.⁴

2
- 79955428497
- The NCGC pharmaceutical collection: A comprehensive resource of clinically approved drugs enabling repurposing and chemical genomics
- Huang R, Southall N, Wang Y, et al.: The NCGC pharmaceutical collection: a comprehensive resource of clinically approved drugs enabling repurposing and chemical genomics. Sci Transl Med 2011;3:80ps16.
- (2011) Sci Transl Med , vol.3
- Huang, R.¹ Southall, N.² Wang, Y.³

3
- 84906303552
- An overview of FDA-approved new molecular entities: 1827-2013
- Kinch MS, Haynesworth A, Kinch SL, Hoyer D: An overview of FDA-approved new molecular entities: 1827-2013. Drug Discov Today 2014;19:1033-1039.
- (2014) Drug Discov Today , vol.19 , pp. 1033-1039
- Kinch, M.S.¹ Haynesworth, A.² Kinch, S.L.³ Hoyer, D.⁴

4
- 84959128138
- Innovation in the pharmaceutical industry: New estimates of R&D costs
- DiMasi JA, Grabowski HG, Hansen RW: Innovation in the pharmaceutical industry: new estimates of R&D costs. J Health Econ 2016;47:20-33.
- (2016) J Health Econ , vol.47 , pp. 20-33
- DiMasi, J.A.¹ Grabowski, H.G.² Hansen, R.W.³

5
- 78049467253
- The importance of new companies for drug discovery: Origins of a decade of new drugs
- Kneller R: The importance of new companies for drug discovery: origins of a decade of new drugs. Nat Rev Drug Discov 2010;9:867-882.
- (2010) Nat Rev Drug Discov , vol.9 , pp. 867-882
- Kneller, R.¹

6
- 84892153139
- Clinical development success rates for investigational drugs
- Hay M, Thomas DW, Craighead JL, Economides C, Rosenthal J: Clinical development success rates for investigational drugs. Nat Biotechnol 2014;32:40-51.
- (2014) Nat Biotechnol , vol.32 , pp. 40-51
- Hay, M.¹ Thomas, D.W.² Craighead, J.L.³ Economides, C.⁴ Rosenthal, J.⁵

7
- 4344668661
- Drug repositioning: Identifying and developing new uses for existing drugs
- Ashburn TT, Thor KB: Drug repositioning: identifying and developing new uses for existing drugs. Nat Rev Drug Discov 2004;3:673-683.
- (2004) Nat Rev Drug Discov , vol.3 , pp. 673-683
- Ashburn, T.T.¹ Thor, K.B.²

8
- 84927689293
- Everolimus in liver transplantation
- Trotter JF, Lizardo-Sanchez L: Everolimus in liver transplantation. Curr Opin Organ Transplant 2014;19:578-582.
- (2014) Curr Opin Organ Transplant , vol.19 , pp. 578-582
- Trotter, J.F.¹ Lizardo-Sanchez, L.²

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.